Harbor Capital Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,757
| Closed | -$1.38M | – | 750 |
|
|
2024
Q1 | $1.38M | Buy |
7,757
+1,495
| +24% | +$266K | 0.18% | 148 |
|
|
2023
Q4 | $777K | Buy |
6,262
+1,148
| +22% | +$142K | 0.15% | 177 |
|
|
2023
Q3 | $593K | Sell |
5,114
-1,864
| -27% | -$216K | 0.13% | 198 |
|
|
2023
Q2 | $819K | Buy |
6,978
+595
| +9% | +$69.9K | 0.16% | 167 |
|
|
2023
Q1 | $511K | Sell |
6,383
-2,118
| -25% | -$170K | 0.15% | 141 |
|
|
2022
Q4 | $673K | Sell |
8,501
-3,276
| -28% | -$260K | 0.65% | 55 |
|
|
2022
Q3 | $821K | Sell |
11,777
-1,277
| -10% | -$89K | 0.75% | 43 |
|
|
2022
Q2 | $857K | Sell |
13,054
-2,251
| -15% | -$148K | 0.65% | 48 |
|
|
2022
Q1 | $1.02M | Sell |
15,305
-3,167
| -17% | -$211K | 0.48% | 61 |
|
|
2021
Q4 | $1.29M | Buy |
+18,472
| New | +$1.29M | 0.47% | 62 |
|